Table 2.
Study | Exposure assessment | Outcome measure¶ | Beta (Confidence Interval) | |
---|---|---|---|---|
| ||||
Folic Acid | Steenweg-de Graaff et al., 2014 | Maternal preconception FAS†: use vs. not | SRS (18-item subset) | −0.042 (−0.068, −0.017) |
| ||||
Braun et al., 2014 | PVS‡: weekly/daily vs. rarely/never | SRS total T scores | −2.7 (−6.5, 1.1) | |
WBF§ per standard deviation increase | 0.6 (0.3,1.5) | |||
| ||||
Vitamin D | Vinkhuyzen et al., 2016 | Maternal 25OHD (nmol/L): deficient (<25) vs. sufficient (≥ 50) | SRS (18-item subset) | 0.06 (0.04, 0.08) |
Neonatal 25OHD (nmol/L): deficient (<25) vs. sufficient (≥ 50) | 0.03 (0.01, 0.05) | |||
| ||||
Lopez-Vicente et al., 2019 | 25OHD3 (ng/mL) per 10-unit increase | CAST | −0.02 (−0.17, 0.12) | |
≥30 ng/mL vs. <20ng/mL 25OHD3 | −0.26 (−0.71, 0.19) | |||
| ||||
Fish and PUFAs | Steenweg-de Graaff et al.,2016 | ω−3:ω−6 ratio quintile: highest vs. lowest | SRS (18-item subset) | −0.024 (−0.047, −0.000) |
1-unit increase in linoleic acid | 0.012 (0.001–0.023) | |||
| ||||
Julvez et al., 2016 | Fish intake quintile: highest vs. lowest | CAST | −0.55 (−1.06, −0.04) | |
| ||||
Vecchione et al, 2020 | Overall fish intake: High (Daily) VS Low (Monthly/None) in second half of pregnancy | SRS raw total score | 5.60 (1.76, 12.97) | |
Salmon: Any VS None | −4.66 (−10.29, 0.97) |
FAS=Folic acid supplementation.
PVS=prenatal vitamin supplementation.
WBF= whole blood folate; 25OHD= 25 hydroxycholecalciferol.
SRS= Social Responsiveness Scale; CAST=Childhood Autism Spectrum Test. Higher scores on both indicate greater ASD traits or severity.